COVID-19 Medication Management at Hotspot Hospitals
The Scottsdale Institute recently hosted a panel event featuring Erin R. Fox, Senior Director Drug Information and Support Services at the University of Utah Health, Benjamin Pennell, Manager Central Pharmacy Operations at Massachusetts General Hospital,Sharon Higgins, Clinical Informatics Pharmacist at Torrance Memorial Medical Center, and David Berkowitz, Performance Center Field Consultant at Omnicell, discussing how COVID-19 has exacerbated the problem of drug shortages.
Epicenter and hospitals are using nearly 75+ different drugs to treat COVID-19 patients. Many of them are in short supply as demand far outpaces industry’s ability to fill and ship orders. In other instances, red tape prevails. While the DEA and other governing bodies are relaxing restrictions to get the supply chain flowing, hospitals and health systems can take steps now with on-hand inventory of these critical drugs to improve visibility and inventory management without stockpiling and exacerbating nationwide drug shortage issues.
The views and opinions expressed in this blog are those of the authors and do not necessarily reflect the official policy or position of any other agency, organization, employer or company. Assumptions made in the analysis are not reflective of the position of any entity other than the author(s). These views are always subject to change, revision, and rethinking at any time and may not be held in perpetuity.